Jason Smith (Chief Technology Officer at Within3)2025-10-24T13:17:47
Within3’s Jason Smith explores how artificial intelligence is breathing new life into next-generation launch situation rooms; delivering actionable insights for pharmaceutical companies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T11:12:00Z
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, Drug Target Review
2026-11-17T09:31:00Z
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2026-08-17T14:16:00
Contributor Dr Rab Prinjha, Drug Target Review
2026-07-15T07:00:00
Contributor Dr Nick Lynch, Dr Raminderpal Singh
2026-09-17T07:00:00
Contributor Dr Roland Bürli, Dr Francesca Capotosti and Dr Antonella Pirone, Drug Target Review
2026-10-22T15:52:00
Contributor Dr Srijit Seal, Dr Raminderpal Singh
2026-06-24T13:00:00
Sponsored by HUB Organoids
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud